Toxicity and Efficacy of Carboplatin and Etoposide in Conjunction with Disruption of the Blood-Brain Tumor Barrier in the Treatment of Intracranial Neoplasms
Paul C. Williams(Oregon Health & Science University), Edward A. Neuwelt(Oregon Health & Science University), Robert E. Brummett(Oregon Health & Science University), Suellen A. Dahlborg, Roman-Goldstein Simon(Oregon Health & Science University), W. David Henner(Oregon Health & Science University), Bruce W. Dana(University of Oklahoma Health Sciences Center), Mara Tableman(Portland State University)
Cited by 108
Related Papers
Engaging neuroscience to advance translational research in brain barrier biology
|Nature reviews. Neuroscience|2011|586
Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check
|Journal of Clinical Oncology|2007|414
Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.
|Journal of Clinical Oncology|1991|383
Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale
|Journal of Clinical Oncology|2012|375
Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier
|Journal of Cerebral Blood Flow & Metabolism|2012|307